GridAI Technologies Corp. (NASDAQ:GRDX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Sapirstein Other companies: INmune Bio Inc. (Director · Since at least Sep 8, 2026); Cocrystal Pharma, Inc. (Chief Executive Officer · Since at least Jun 3, 2026); ZyVersa Therapeutics, Inc. (Director · Since at least Jan 5, 2023); Onconetix, Inc. (Director · Feb 23, 2022 – Sep 26, 2024 · Past); Blue Water Acquisition Corp (Director · Dec 15, 2020 – Dec 15, 2020 · Past); Marizyme, Inc. (Interim CEO, Director · Sep 10, 2020 – Mar 5, 2021 · Past); Lunai Bioworks Inc. (Director · Mar 6, 2018 – Jun 25, 2024 · Past); Hepion Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jan 3, 2018 – Jan 3, 2018 · Past); RespireRx Pharmaceuticals Inc (Director · Dec 9, 2017 – Dec 9, 2017 · Past) | Chairman and CEO, Director · Oct 8, 2019 – Jul 2, 2024 · Past |
| Mary Theresa Coelho Other companies: Hookipa Pharma Inc (EVP and CFO, Director · Since at least Apr 3, 2023); Inotiv, Inc. (Director · Oct 16, 2023 – Apr 1, 2025 · Past); Gamida Cell Ltd (Chief Financial Officer · May 22, 2023 – Jun 12, 2023 · Past); CinCor Pharma Inc (EVP CFO & Chief BD Officer · Jan 6, 2022 – Jan 11, 2022 · Past); BioDelivery Sciences International Inc (See Remarks · Jan 15, 2019 – Jan 29, 2021 · Past); Balchem Corporation (Chief Financial Officer · Oct 23, 2017 – Oct 26, 2018 · Past) | Director · Aug 11, 2021 – Jan 2, 2024 · Past |
| Charles J. Casamento Other companies: GT Biopharma, Inc. (Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); Relmada Therapeutics, Inc. (Chairman of the Board · Since at least Oct 20, 2017); PaxMedica, Inc. (Director · Oct 1, 2022 – Mar 12, 2024 · Past); International Stem Cell Corporation (Director · Mar 31, 2016 – Jun 21, 2018 · Past) | Director · Mar 3, 2017 – Jan 2, 2024 · Past |
| Johan M Spoor Other companies: Perspective Therapeutics, Inc. (Chief Executive Officer, Director · Since at least Feb 3, 2023); MetaStat Inc (Director · May 22, 2012 – Dec 31, 2014 · Past); FluoroPharma Medical Inc (CEO, PRESIDENT, CHAIRMAN, Director · Nov 18, 2011 – Jan 7, 2014 · Past) | Director · Oct 11, 2016 – Apr 6, 2020 · Past |
| Sarah Romano Other companies: SS Innovations International Inc. (CFO · Since at least Jul 15, 2026); Onconetix, Inc. (Director · Since at least Dec 5, 2025); Vicarious Surgical, Inc. (Chief Financial Officer · Since at least Apr 1, 2025) | Chief Financial Officer · Jan 3, 2023 – Jan 6, 2025 · Past |
| Anna Skowron Other companies: Powell Max Limited (CFO · Since at least Mar 10, 2026); Titan Environmental Solutions Inc (CFO and Secretary · Apr 15, 2025 – Apr 15, 2025 · Past) | Interim CFO · Since at least Mar 7, 2025 |
| Chaitan Phd Khosla Other companies: Protagonist Therapeutics, Inc. (Director · Aug 10, 2016 – Aug 11, 2020 · Past); Kosan Biosciences Inc (Director · May 25, 2007 – Jun 26, 2008 · Past) | Director · Mar 13, 2024 – Jun 11, 2024 · Past |
| Geordan Pursglove Other companies: Powell Max Limited (CEO and Chairman, Director · Since at least Mar 18, 2026); Lixte Biotechnology Holdings, Inc. (Chairman of the Board of Directors, President and Chief Executive Officer · Since at least Jun 16, 2025) | Director · Since at least Aug 11, 2025 |
| Jason Sawyer Other companies: Greenland Mines Ltd (Director · Since at least Jul 22, 2026); Lixte Biotechnology Holdings, Inc. (Director · Since at least Mar 31, 2026) | Chief Executive Officer, Director · Since at least Mar 31, 2026 |
| Maged Shenouda Other companies: Relmada Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 12, 2015); Protea Biosciences Group (Director · Apr 17, 2015 – Dec 18, 2015 · Past) | CHIEF FINANCIAL OFFICER, Director · Oct 11, 2016 – Dec 28, 2018 · Past |
| Richard Paolone Other companies: Mixed Martial Arts Group Limited (Director · Since at least Apr 22, 2025); iSpecimen Inc. (Director · Sep 25, 2024 – Sep 25, 2024 · Past) | Interim CEO, Director · Feb 3, 2025 – Feb 3, 2025 · Past |
| Timothy R. Ramdeen Other companies: Tribeca Strategic Acquisition Corp. (Chairman & Chief Executive Officer · Since at least May 28, 2026); Onconetix, Inc. (Director · Since at least Jan 13, 2023) | Director · Aug 9, 2024 – Aug 9, 2024 · Past |
| Alastair Riddell | Director · Oct 11, 2016 – Jan 2, 2024 · Past |
| Daniel Dupret | CHIEF SCIENTIFIC OFFICER · Oct 11, 2016 – Jul 12, 2018 · Past |
| Edward Borkowski | Director · Since at least Jan 1, 2026 |
| Jack Syage | Director · Since at least Mar 13, 2024 |
| James Pennington | CHIEF MEDICAL OFFICER · May 29, 2018 – Jan 3, 2022 · Past |
| Jérôme Cliche | For Investor Relations , please · Since at least Apr 28, 2026 |
| Manpreet Uppal | Director · Since at least Feb 3, 2025 |
| Marshall Chapin | CEO of AI and Energy Infrastructure Subsidiary · Jan 28, 2026 – Nov 5, 2026 · Past |
| Tim Healy | Executive Chairman of Operating Subsidiary · Feb 4, 2026 – Nov 5, 2026 · Past |
| Vern Lee Schramm | Director · Jan 4, 2021 – Jan 3, 2022 · Past |